Evaluation of the usefulness of sensitization to aeroallergens as a model for canine atopic dermatitis in genetically predisposed Beagles

Katrin S. Egli Institute for Animal Pathology, University of Bern, Bern, Switzerland.

Search for other papers by Katrin S. Egli in
Current site
Google Scholar
PubMed
Close
 DVM
,
Brigitte Schiessl Novartis, Centre de Recherche Santé Animale SA, St Aubin, Switzerland.

Search for other papers by Brigitte Schiessl in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Petra J. Roosje Institute for Animal Pathology, University of Bern, Bern, Switzerland.
Interdisciplinary Dermatology Unit, Department of Clinical Veterinary Medicine, University of Bern, Bern, Switzerland.

Search for other papers by Petra J. Roosje in
Current site
Google Scholar
PubMed
Close
 DVM
,
Wolfgang Seewald Novartis, Animal Health Inc,Basel.

Search for other papers by Wolfgang Seewald in
Current site
Google Scholar
PubMed
Close
,
Ursula Forster Institute for Animal Pathology, University of Bern, Bern, Switzerland.

Search for other papers by Ursula Forster in
Current site
Google Scholar
PubMed
Close
,
John E. Peel Novartis, Centre de Recherche Santé Animale SA,St Aubin, Switzerland.

Search for other papers by John E. Peel in
Current site
Google Scholar
PubMed
Close
 BVSC
, and
Monika M. Welle Institute for Animal Pathology, University of Bern, Bern, Switzerland.

Search for other papers by Monika M. Welle in
Current site
Google Scholar
PubMed
Close
 PD, DVM

Abstract

Objective—To evaluate a model for atopic dermatitis (AD) and to measure the effect of sensitization in Beagles genetically predisposed to produce high serum concentrations of allergen specific IgE.

Animals—22 laboratory Beagles.

Procedure—Seventeen dogs were sensitized from birth to 3 allergens (recombinant birch pollen, Dermatophagoides pteronyssinus, and D farinae). Five nonsensitized dogs from the same litters served as controls. Clinical scoring, regular intradermal testing, measurement of serum concentrations of allergen-specific IgE, and collection of biopsy specimens of skin at 23, 32, and 43 weeks of age were performed. Serial tissue sections were stained for identification of IgE+ cells, mast cells and their subtypes, T-cells, Langerhans cells, and major histocompatibility complex class-II+ cells. At the age of 15 months, dogs were continuously exposed to 2 µg of mite allergen/ g of dust.

Results—Sensitized dogs had positive intradermal test reactions and significantly higher serum concentrations of allergen specific IgE, compared with nonsensitized dogs. In sensitized and nonsensitized dogs, a significantly higher number of mast cells was found at predilection sites, compared with the control biopsy site. The number of mast cells at predilection sites increased with age. Sensitization significantly increased the number of epidermal Langerhans cells by 23 weeks of age. The number of epidermal Langerhans cells significantly increased in nonsensitized dogs by 32 weeks of age. Clinical scoring only revealed mild transient erythema in some dogs.

Conclusion and Clinical Relevance—Increases in concentrations of serum allergen-specific IgE and exposure to allergens is not sufficient to induce clinical signs of AD in genetically predisposed dogs. (Am J Vet Res 2002;63:1329–1336)

Abstract

Objective—To evaluate a model for atopic dermatitis (AD) and to measure the effect of sensitization in Beagles genetically predisposed to produce high serum concentrations of allergen specific IgE.

Animals—22 laboratory Beagles.

Procedure—Seventeen dogs were sensitized from birth to 3 allergens (recombinant birch pollen, Dermatophagoides pteronyssinus, and D farinae). Five nonsensitized dogs from the same litters served as controls. Clinical scoring, regular intradermal testing, measurement of serum concentrations of allergen-specific IgE, and collection of biopsy specimens of skin at 23, 32, and 43 weeks of age were performed. Serial tissue sections were stained for identification of IgE+ cells, mast cells and their subtypes, T-cells, Langerhans cells, and major histocompatibility complex class-II+ cells. At the age of 15 months, dogs were continuously exposed to 2 µg of mite allergen/ g of dust.

Results—Sensitized dogs had positive intradermal test reactions and significantly higher serum concentrations of allergen specific IgE, compared with nonsensitized dogs. In sensitized and nonsensitized dogs, a significantly higher number of mast cells was found at predilection sites, compared with the control biopsy site. The number of mast cells at predilection sites increased with age. Sensitization significantly increased the number of epidermal Langerhans cells by 23 weeks of age. The number of epidermal Langerhans cells significantly increased in nonsensitized dogs by 32 weeks of age. Clinical scoring only revealed mild transient erythema in some dogs.

Conclusion and Clinical Relevance—Increases in concentrations of serum allergen-specific IgE and exposure to allergens is not sufficient to induce clinical signs of AD in genetically predisposed dogs. (Am J Vet Res 2002;63:1329–1336)

Advertisement